By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company BioCorRx Inc.

BioCorRx Inc. (BICX)

OTC Currency in USD
$0.45
+$0.19
+72.55%
Last Update: 2 Sept 2025, 19:58
$8.43M
Market Cap
-1.12
P/E Ratio (TTM)
Forward Dividend Yield
$0.20 - $1.45
52 Week Range

BICX Stock Price Chart

Explore BioCorRx Inc. interactive price chart. Choose custom timeframes to analyze BICX price movements and trends.

BICX Company Profile

Discover essential business fundamentals and corporate details for BioCorRx Inc. (BICX) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Care Facilities

IPO Date

31 Aug 2010

Employees

3.00

CEO

Lourdes Felix

Description

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.

BICX Financial Timeline

Browse a chronological timeline of BioCorRx Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 13 May 2026

Upcoming earnings on 30 Mar 2026

Upcoming earnings on 13 Nov 2025

EPS estimate is -$0.06.

Earnings released on 14 Aug 2025

EPS came in at -$0.07 , while revenue for the quarter reached $178.24K , missing expectations by -6.19%.

Earnings released on 15 May 2025

EPS came in at -$0.06 , while revenue for the quarter reached $134.90K .

Earnings released on 31 Mar 2025

EPS came in at -$0.08 , while revenue for the quarter reached $7.67K .

Earnings released on 14 Nov 2024

EPS came in at -$0.14 .

Earnings released on 13 Aug 2024

EPS came in at -$0.13 , while revenue for the quarter reached $4.05K .

Earnings released on 1 Apr 2024

EPS came in at -$0.11 , while revenue for the quarter reached $3.62K .

Earnings released on 12 Feb 2024

EPS came in at -$0.11 , while revenue for the quarter reached $18.94K .

Earnings released on 14 Nov 2023

EPS came in at -$0.10 , while revenue for the quarter reached $10.15K .

Earnings released on 14 Aug 2023

EPS came in at -$0.11 , while revenue for the quarter reached $19.64K .

Earnings released on 15 May 2023

EPS came in at -$0.12 , while revenue for the quarter reached $40.44K , missing expectations by -89.89%.

Earnings released on 31 Mar 2023

EPS came in at -$0.15 , while revenue for the quarter reached $82.88K , missing expectations by -11.83%.

Earnings released on 15 Nov 2022

EPS came in at -$0.13 , while revenue for the quarter reached $94.44K .

Earnings released on 15 Aug 2022

EPS came in at -$0.19 , while revenue for the quarter reached $16.00K .

Earnings released on 16 May 2022

EPS came in at -$0.14 , while revenue for the quarter reached $20.52K .

Earnings released on 31 Mar 2022

EPS came in at -$0.19 , while revenue for the quarter reached $13.61K , beating expectations by +51.26%.

Earnings released on 16 Nov 2021

EPS came in at -$0.21 , while revenue for the quarter reached $8.82K , missing expectations by -2.03%.

Earnings released on 16 Aug 2021

EPS came in at -$0.16 , while revenue for the quarter reached $15.72K .

Earnings released on 17 May 2021

EPS came in at -$0.26 , while revenue for the quarter reached $10.12K .

Earnings released on 1 Apr 2021

EPS came in at -$0.17 , while revenue for the quarter reached $22.22K .

Earnings released on 16 Nov 2020

EPS came in at -$0.14 , while revenue for the quarter reached $29.81K .

BICX Stock Performance

Access detailed BICX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run